Literature DB >> 19096862

Rhinitis medicamentosa: what an otolaryngologist needs to know.

Jayesh Doshi1.   

Abstract

Rhinitis medicamentosa (RM) is a drug induced non-allergic rhinitis associated with prolonged use of topical nasal decongestants. This review discusses the nasal mucosa microcirculation, basic pharmacology of topical decongestants and the theories of the pathophysiology of RM. Diagnostic problems are discussed in addition to the current opinion on how to treat RM.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19096862     DOI： 10.1007/s00405-008-0896-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


  16 in total

Review 1.  Rhinitis medicamentosa.

Authors:  Peter M Graf
Journal:  Clin Allergy Immunol       Date:  2007

2.  Mechanism of decongestant activity of alpha 2-adrenoceptor agonists.

Authors:  M R Corboz; M A Rivelli; G G Mingo; R L McLeod; L Varty; Y Jia; J A Hey
Journal:  Pulm Pharmacol Ther       Date:  2007-07-17       Impact factor: 3.410

Review 3.  Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use.

Authors:  Desiderio Passàli; Lorenzo Salerni; Giulio Cesare Passàli; Francesco Maria Passàli; Luisa Bellussi
Journal:  Expert Opin Drug Saf       Date:  2006-11       Impact factor: 4.250

4.  Nasal decongestant therapy.

Authors:  R D Stride
Journal:  Br J Clin Pract       Date:  1967-11-11

5.  Pharmacological characterization of postjunctional alpha-adrenoceptors in human nasal mucosa.

Authors:  Michel R Corboz; Maria A Rivelli; Lori Varty; Jennifer Mutter; Mark Cartwright; Charles A Rizzo; Stephen P Eckel; John C Anthes; John A Hey
Journal:  Am J Rhinol       Date:  2005 Sep-Oct

6.  Rhinitis medicamentosa. An experimental histopathological and histochemical study.

Authors:  S S Elwany; W M Stephanos
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1983       Impact factor: 1.538

7.  Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.

Authors:  J S Lacroix
Journal:  Acta Physiol Scand Suppl       Date:  1989

8.  Electron microscope study of effect of benzalkonium chloride and edetate disodium on cell envelope of Pseudomonas aeruginosa.

Authors:  R M Richards; R H Cavill
Journal:  J Pharm Sci       Date:  1976-01       Impact factor: 3.534

9.  Rhinitis medicamentosa.

Authors:  R J Toohill; R H Lehman; T W Grossman; T P Belson
Journal:  Laryngoscope       Date:  1981-10       Impact factor: 3.325

10.  The "nose drop nose" due to oxymetazoline (Afrin) and other topical vasoconstrictors.

Authors:  A R Feinberg; S M Feinberg
Journal:  IMJ Ill Med J       Date:  1971-07
View more
  5 in total

1.  Systemic side effects of locally used oxymetazoline.

Authors:  Recep Dokuyucu; Hasan Gokce; Mustafa Sahan; Fatih Sefil; Zeynel Abidin Tas; Okan Tutuk; Atakan Ozturk; Cemil Tumer; Cengiz Cevik
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.

Authors:  Behram Cam; Murat Sari; Ahmet Midi; Ozgül Gergin
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-29       Impact factor: 2.503

3.  The effectiveness of long-term course of Sterimar Mn nasal spray for treatment of the recurrence rates of acute allergic rhinitis in patients with chronic allergic rhinitis.

Authors:  Michele Grasso; Marco de Vincentiis; Griselda Agolli; Francesco Cilurzo; Raffaele Grasso
Journal:  Drug Des Devel Ther       Date:  2018-04-03       Impact factor: 4.162

4.  Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.

Authors:  James Fowler; Christopher J Chin; Emad Massoud
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-12-09

5.  Inflammatory diseases of the nasal cavities and paranasal sinuses.

Authors:  Tim Helliwell
Journal:  Diagn Histopathol (Oxf)       Date:  2010-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.